Literature DB >> 25335843

Aligning product development and user perspectives: social-behavioural dimensions of multipurpose prevention technologies.

M Brady1, E Tolley.   

Abstract

Multipurpose prevention technologies provide a compelling response to the multiple and reinforcing sexual and reproductive health risks faced by women globally. To ensure that this potential is realised, product-specific characteristics and their social-behavioural correlates must be considered early in the product development process. This paper provides an overview of the key user-related social and behavioural dimensions of three broad categories of multipurpose prevention technologies: 1) sustained release vaginal rings, 2) pericoital vaginal products, and 3) co-formulated or co-administered injectables. The authors build upon the broad parameters of Target Product Profiles for such products, aligning them with user perspective considerations.
© 2014 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Acceptability; multipurpose prevention technologies; social-behavioural; user perspectives

Mesh:

Year:  2014        PMID: 25335843     DOI: 10.1111/1471-0528.12844

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  17 in total

1.  Design of an Implant for Long-Acting HIV Pre-Exposure Prophylaxis: Input from South African Health Care Providers.

Authors:  Emily A Krogstad; Elizabeth T Montgomery; Millicent Atujuna; Alexandra M Minnis; Shannon O'Rourke; Khatija Ahmed; Linda-Gail Bekker; Ariane van der Straten
Journal:  AIDS Patient Care STDS       Date:  2019-04       Impact factor: 5.078

2.  Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.

Authors:  Jenna S Hynes; Anandi N Sheth; Eva Lathrop; Jessica M Sales; Lisa B Haddad
Journal:  J Womens Health (Larchmt)       Date:  2019-01-04       Impact factor: 2.681

3.  Preferences for Multipurpose Technology and Non-oral Methods of Antiretroviral Therapy Among Women Living With HIV in Western Kenya: A Survey Study.

Authors:  Caitlin Bernard; Beatrice Jakait; William F Fadel; A Rain Mocello; Maricianah A Onono; Elizabeth A Bukusi; Kara K Wools-Kaloustian; Craig R Cohen; Rena C Patel
Journal:  Front Glob Womens Health       Date:  2022-05-19

4.  Characteristics of women screened for a contraceptive intravaginal ring study in Kisumu, Kenya, 2014.

Authors:  Eleanor McLellan-Lemal; Deborah A Gust; Roman Gvetadze; Melissa Furtado; Fredrick O Otieno; Mitesh Desai; Clement Zeh; Taraz Samandari; Beatrice Nyagol; Esther M Makanga
Journal:  Res J Womens Health       Date:  2016-07-06

5.  Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States.

Authors:  Jenna S Hynes; Jessica M Sales; Anandi N Sheth; Eva Lathrop; Lisa B Haddad
Journal:  Contraception       Date:  2017-10-18       Impact factor: 3.375

Review 6.  Multipurpose prevention technologies: the future of HIV and STI protection.

Authors:  José A Fernández-Romero; Carolyn Deal; Betsy C Herold; John Schiller; Dorothy Patton; Thomas Zydowsky; Joe Romano; Christopher D Petro; Manjulaa Narasimhan
Journal:  Trends Microbiol       Date:  2015-03-07       Impact factor: 17.079

7.  The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa.

Authors:  Matthew Quaife; Fern Terris-Prestholt; Robyn Eakle; Maria A Cabrera Escobar; Maggie Kilbourne-Brook; Mercy Mvundura; Gesine Meyer-Rath; Sinead Delany-Moretlwe; Peter Vickerman
Journal:  J Int AIDS Soc       Date:  2018-03       Impact factor: 5.396

8.  Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.

Authors:  Alexandra M Minnis; Sarah T Roberts; Kawango Agot; Rachel Weinrib; Khatija Ahmed; Kgahlisho Manenzhe; Fredrick Owino; Ariane van der Straten
Journal:  AIDS Behav       Date:  2018-08

9.  Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake.

Authors:  Lorna Begg; Rebecca Brodsky; Barbara Friedland; Sanyukta Mathur; Jim Sailer; George Creasy
Journal:  BMJ Sex Reprod Health       Date:  2020-07-31

10.  The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention.

Authors:  Ariane van der Straten; Kawango Agot; Khatija Ahmed; Rachel Weinrib; Erica N Browne; Kgahlisho Manenzhe; Fredrick Owino; Jill Schwartz; Alexandra Minnis
Journal:  J Int AIDS Soc       Date:  2018-03       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.